Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients

Eur J Immunol. 2019 Dec;49(12):2204-2221. doi: 10.1002/eji.201948223. Epub 2019 Aug 16.

Abstract

Patients with primary progressive (PP) and secondary progressive (SP) forms of multiple sclerosis (MS) exhibit a sustained increase in the number of Th1, T cytotoxic type-1 and Th17 cells in peripheral blood, suggesting that the progressive phase is characterized by a permanent peripheral immune activation. As T cell functionality and activation are strictly connected to their metabolic profile, we investigated the mitochondrial functionality and metabolic changes of T cell subpopulations in a cohort of progressive MS patients. T cells from progressive patients were characterized by low proliferation and increase of terminally differentiated/exhausted cells. T cells from PP patients showed lower Oxygen Consumption Rate and Extracellular Acidification Rate, lower mitochondrial mass, membrane potential and respiration than those of SP patients, a downregulation of transcription factors supporting respiration and higher tendency to shift towards glycolysis upon stimulation. Furthermore, PP effector memory T cells were characterized by higher Glucose transporter -1 levels and a higher expression of glycolytic-supporting genes if compared to SP patients. Overall, our data suggest that profound differences exist in the phenotypic and metabolic features of T cells from PP and SP patients, even though the two clinical phenotypes are considered part of the same disease spectrum.

Keywords: T cells; flow cytometry; metabolism; mitochondria; multiple sclerosis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Glucose Transporter Type 1 / immunology
  • Glucose Transporter Type 1 / metabolism
  • Humans
  • Immunologic Memory*
  • Middle Aged
  • Mitochondria* / immunology
  • Mitochondria* / metabolism
  • Mitochondria* / pathology
  • Multiple Sclerosis* / immunology
  • Multiple Sclerosis* / metabolism
  • Multiple Sclerosis* / pathology
  • Oxygen Consumption / immunology*
  • T-Lymphocytes* / immunology
  • T-Lymphocytes* / metabolism
  • T-Lymphocytes* / pathology

Substances

  • Glucose Transporter Type 1